Herbal Medicines and Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study

Overview

Journal Obstet Gynecol Int

Publisher Wiley

Specialty Gynecology & Obstetrics

Date 2016 Oct 1

PMID 27688772

Authors

Athar Rasekhjahromi

Masoumeh Hosseinpoor

Farzaneh Alipour

Mehrnoosh Maalhagh

Saeed Sobhanian

Affiliations

Soon will be listed here.

Abstract

Background. The aim of this study was to assess the association between herbal medication and OHSS. Methods. This retrospective cohort study was conducted with 101 polycystic ovary syndrome patients. 66 patients took conventional pharmacological medications and 35 took herbal medications. Data were analyzed by statistical test including Fisher's Exact and binominal logistic regression. P < 0.05 was considered significant. Results. Of the 101 females, 53 were married and 48 were single. There was no significant association between the groups in marriage. No significant association was found in mean age between the two groups (23.9 ± 5.8 years in the control group versus 26.3 ± 6.7 years in the case group). There was a significant difference between the two groups .After adding the dependent (OHSS prevalence) and independent (marriage and group) variables into the model, the Hosmer-Lemeshow test showed suitability. Variances analyzed with this model ranged between 29.4% and 40.7%. Conclusion. The indiscriminate use of herbs is correlated with OHSS. Because patients increasingly consume herbs, they should be aware of potential side effects. However, appropriate dosages of herbs could be obtained for use instead of conventional treatments, which often have side effects.

References

Skinner C, Rangasami J . Preoperative use of herbal medicines: a patient survey. Br J Anaesth. 2002; 89(5):792-5. View

Au A, Ko R, Boo F, Hsu R, Perez G, Yang Z . Screening methods for drugs and heavy metals in Chinese patent medicines. Bull Environ Contam Toxicol. 2000; 65(1):112-9. DOI: 10.1007/s0012800102. View

May B, Kohler S, Schneider B . Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther. 2000; 14(12):1671-7. DOI: 10.1046/j.1365-2036.2000.00873.x. View

Egbase P, Al-Sharhan M, Grudzinskas J . 'Early coasting' in patients with polycystic ovarian syndrome is consistent with good clinical outcome. Hum Reprod. 2002; 17(5):1212-6. DOI: 10.1093/humrep/17.5.1212. View

Terry R, Posadzki P, Watson L, Ernst E . The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain Med. 2011; 12(12):1808-18. DOI: 10.1111/j.1526-4637.2011.01261.x. View

Cao H, Han M, Ng E, Wu X, Flower A, Lewith G . Can Chinese herbal medicine improve outcomes of in vitro fertilization? A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2013; 8(12):e81650. PMC: 3858252. DOI: 10.1371/journal.pone.0081650. View

Asch R, Li H, Balmaceda J, Weckstein L, Stone S . Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod. 1991; 6(10):1395-9. DOI: 10.1093/oxfordjournals.humrep.a137276. View

Raynor D, Dickinson R, Knapp P, Long A, Nicolson D . Buyer beware? Does the information provided with herbal products available over the counter enable safe use?. BMC Med. 2011; 9:94. PMC: 3180693. DOI: 10.1186/1741-7015-9-94. View

Baker W, Gutierrez-Williams G, White C, Kluger J, Coleman C . Effect of cinnamon on glucose control and lipid parameters. Diabetes Care. 2007; 31(1):41-3. DOI: 10.2337/dc07-1711. View

10.

Schenker J, Weinstein D . Ovarian hyperstimulation syndrome: a current survey. Fertil Steril. 1978; 30(3):255-68. DOI: 10.1016/s0015-0282(16)43508-9. View

11.

Habersang S, Leuschner F, Isaac O, THIEMER K . [Pharmacological studies with compounds of chamomile. IV. Studies on toxicity of (-)-alpha-bisabolol (author's transl)]. Planta Med. 1979; 37(2):115-23. DOI: 10.1055/s-0028-1097310. View

12.

Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S . Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med. 2003; 349(8):760-6. DOI: 10.1056/NEJMoa030064. View

13.

Barak V, Elchalal U, Edelstein M, Kalickman I, Lewin A, Abramov Y . Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome. Fertil Steril. 2004; 82(2):415-20. DOI: 10.1016/j.fertnstert.2004.03.024. View

14.

Onofriescu A, Bors A, Luca A, Holicov M, Onofriescu M, Vulpoi C . GnRH Antagonist IVF Protocol in PCOS. Curr Health Sci J. 2014; 39(1):20-5. PMC: 3945257. View

15.

Norman R, Dewailly D, Legro R, Hickey T . Polycystic ovary syndrome. Lancet. 2007; 370(9588):685-97. DOI: 10.1016/S0140-6736(07)61345-2. View

16.

Srivastava J, Shankar E, Gupta S . Chamomile: A herbal medicine of the past with bright future. Mol Med Rep. 2010; 3(6):895-901. PMC: 2995283. DOI: 10.3892/mmr.2010.377. View

17.

Kohlert C, Schindler G, Marz R, Abel G, Brinkhaus B, Derendorf H . Systemic availability and pharmacokinetics of thymol in humans. J Clin Pharmacol. 2002; 42(7):731-7. DOI: 10.1177/009127002401102678. View

18.

Delvigne A, Rozenberg S . Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002; 8(6):559-77. DOI: 10.1093/humupd/8.6.559. View

19.

Budev M, Arroliga A, Falcone T . Ovarian hyperstimulation syndrome. Crit Care Med. 2005; 33(10 Suppl):S301-6. DOI: 10.1097/01.ccm.0000182795.31757.ce. View

20.

Singh A, Rao A . Evaluation of the modulatory influence of black pepper (Piper nigrum, L.) on the hepatic detoxication system. Cancer Lett. 1993; 72(1-2):5-9. DOI: 10.1016/0304-3835(93)90003-r. View